| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000031049 |
| Receipt No. | R000035203 |
| Official scientific title of the study | Study to investigate the influence of meals ingested for dinner on nighttime blood glucose level transition |
| Date of disclosure of the study information | 2018/02/10 |
| Last modified on | 2018/06/22 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Study to investigate the influence of meals ingested for dinner on nighttime blood glucose level transition | |
| Title of the study (Brief title) | Study to investigate the influence of meals ingested for dinner on nighttime blood glucose level transition | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to examine how the diet contents at dinner will influence the transition of blood sugar at sleep and on the next day. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Night of the blood glucose level,AUC |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The contents of dinner are as follows.
Day 1 Only rice Day 2 a bowl of rice topped with beef Day 3 hamburger steak Day 4 hamburgers |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | [1]Aged between 20 and 59
[2]Individuals who are healthy and do not treat any disease [3]Individuals whose written informed consent has been obtained [4]Individuals who can have an examination on a designated check day [5]Individuals judged appropriate for the study by the principal |
|||
| Key exclusion criteria | [1]Individuals using medical products
[2]Individuals who are or are under treatment or have a history of Impaired Glucose Tolerance,mental disabilities,sleep disorder,hypertension,diabetes,fat metabolism or the other serious dysfunctions [3]Individuals who used a drug to treat in the past 1 month (One-shot medicine of a headache, menstrual pain and a cold removes it.) [4]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung disease,or blood disease [5]Individual who have digestive organ disease(disease of an appendix is removed) [6]Individuals whose BMI is over 30 kg/m2 [7]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [8]Individuals with serious anemia [9]Individuals who are sensitive to test products or Individual with fear who causes severe allergy in a food and medical supplies [10]Individual who is pregnant or lactate [11]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments of glycometabolism in the past 3 month or will ingest those foods during the test period [12]Individuals judged inappropriate for the study by the principal |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshikazu Yonei |
| Organization | Faculty of Life and Medical Sciences,Doshisha University |
| Division name | Anti-Aging Medical Research Center |
| Address | 1-3 Tatara Miyakodani,Kyotanabe City,Kyoto |
| TEL | 0774-65-6394 |
| yyonei@mail.doshisha.ac.jp | |
| Public contact | |
| Name of contact person | Mari Ogura |
| Organization | Doshisha University |
| Division name | Graduate School of Life and Medical Sciences, |
| Address | 1-3 Tatara Miyakodani,Kyotanabe City,Kyoto |
| TEL | 0774-65-6382 |
| Homepage URL | |
| m-ogura@po.kbu.ac.jp | |
| Sponsor | |
| Institute | Anti-Aging Medical Research Center,Faculty of Life and Medical Sciences,Doshisha University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | YOSHINOYA HOLDINGS CO., LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 金沢浦田クリニック(石川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035203 |